Fluidigm Corporation (FLDM) Drops 16.59% on February 08

Equities Staff |

Fluidigm Corporation (FLDM) was one of the Russell 2000's biggest losers for Monday February 08 as the stock slid 16.59% to $5.41, a loss of $-1.075 per share. Starting at an opening price of $6.42 a share, the stock traded between $5.24 and $6.44 over the course of the trading day. Volume was 1.04 million shares over 6,133 trades, against an average daily volume of 568,474 shares and a total float of 28.79 million.

The losses send Fluidigm Corporation down to a market cap of $155.62 million. In the last year, Fluidigm Corporation has traded between $46.38 and $4.84, and its 50-day SMA is currently $9.11 and 200-day SMA is $15.86.

Fluidigm Corp creates, manufactures, and markets technologies and life-science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon microfluidics and mass cytometry technologies.

Fluidigm Corporation is based out of South San Francisco, CA and has some 474 employees. Its CEO is Gajus Worthington.

For a complete fundamental analysis analysis of Fluidigm Corporation, check out Equities.com’s Stock Valuation Analysis report for FLDM. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Kiwa Bio-Tech Products Group Corp

Kiwa Bio-Tech Products Group Corp develops, manufactures, distributes and markets, cost-effective and environmentally safe bio-technological products for agriculture in China.

Private Markets

Knightscope

Autonomous security robots providing advanced detection capabilities at $7 per hour - aiming to define the future of security. Help #StopTheViolence.

Wealthfront

Wealthfront is an automated investment service that serves as an alternative to traditional financial advisory services. The company manages a diversified, continually rebalanced portfolio of index funds on their clients’…